Schade AE - Search Results

1

Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F.

Gibson SE, Schade AE, Szpurka H, Bak B, Maciejewski JP, Hsi ED. Gibson SE, et al. Among authors: schade ae. Hum Pathol. 2008 Jul;39(7):1111-4. doi: 10.1016/j.humpath.2007.10.034. Epub 2008 May 13. Hum Pathol. 2008. PMID: 18479730

2

Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells.

Szpurka H, Schade AE, Jankowska AM, Maciejewski JP. Szpurka H, et al. Among authors: schade ae. Br J Haematol. 2008 Jul;142(3):413-22. doi: 10.1111/j.1365-2141.2008.07203.x. Epub 2008 Jun 9. Br J Haematol. 2008. PMID: 18544084

3

Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis.

Schade AE, Powers JJ, Wlodarski MW, Maciejewski JP. Schade AE, et al. Blood. 2006 Jun 15;107(12):4834-40. doi: 10.1182/blood-2005-08-3076. Epub 2006 Feb 16. Blood. 2006. PMID: 16484592 Free PMC article.

4

Pathophysiology defined by altered signal transduction pathways: the role of JAK-STAT and PI3K signaling in leukemic large granular lymphocytes.

Schade AE, Wlodarski MW, Maciejewski JP. Schade AE, et al. Cell Cycle. 2006 Nov;5(22):2571-4. doi: 10.4161/cc.5.22.3449. Epub 2006 Nov 15. Cell Cycle. 2006. PMID: 17172839 Review.

5

Immunomodulation via targeted inhibition of antigen receptor signal transduction.

Schade AE, Gonzalez-Stawinski G. Schade AE, et al. Cardiovasc Hematol Disord Drug Targets. 2008 Mar;8(1):1-6. doi: 10.2174/187152908783884948. Cardiovasc Hematol Disord Drug Targets. 2008. PMID: 18336251 Review.

6

Cutting edge: extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength.

Schade AE, Levine AD. Schade AE, et al. J Immunol. 2004 May 15;172(10):5828-32. doi: 10.4049/jimmunol.172.10.5828. J Immunol. 2004. PMID: 15128760

7

Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.

Schade AE, Schieven GL, Townsend R, Jankowska AM, Susulic V, Zhang R, Szpurka H, Maciejewski JP. Schade AE, et al. Blood. 2008 Feb 1;111(3):1366-77. doi: 10.1182/blood-2007-04-084814. Epub 2007 Oct 25. Blood. 2008. PMID: 17962511 Free PMC article.

8

Signal transduction through the T cell receptor is dynamically regulated by balancing kinase and phosphatase activities.

Schade AE, Levine AD. Schade AE, et al. Biochem Biophys Res Commun. 2002 Aug 23;296(3):637-43. doi: 10.1016/s0006-291x(02)00925-7. Biochem Biophys Res Commun. 2002. PMID: 12176029

9

An algorithm for managing warfarin resistance.

Osinbowale O, Al Malki M, Schade A, Bartholomew JR. Osinbowale O, et al. Cleve Clin J Med. 2009 Dec;76(12):724-30. doi: 10.3949/ccjm.76a.09062. Cleve Clin J Med. 2009. PMID: 19952297 Review.

10

Phosphatases in concert with kinases set the gain for signal transduction through the T cell receptor.

Schade AE, Levine AD. Schade AE, et al. Mol Immunol. 2003 Dec;40(8):531-7. doi: 10.1016/s0161-5890(03)00170-6. Mol Immunol. 2003. PMID: 14563372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results